Key Takeaways
1. Huawei is developing a new wearable device focused on blood glucose monitoring, following the introduction of the Watch 4.
2. The Watch 4’s blood glucose tracking feature is currently limited to the Chinese version of the device.
3. A new feature called the Diabetes Risk Study will be available on the Watch GT 6 Pro smartwatch, priced at €314.90.
4. The upcoming blood glucose monitoring device is rumored to have “more accurate” technology, but no supporting evidence has been provided.
5. Huawei plans to unveil this new device in the second quarter of 2026, with uncertainty about its availability in markets outside of China.
A new wearable device from Huawei focused on blood sugar monitoring is reportedly in the works. In 2023, the brand introduced its first smartwatch capable of tracking blood glucose levels, known as the Watch 4. However, this feature is limited to the Chinese version of the device. Recently, Huawei also revealed a new feature called the Diabetes Risk Study, which will be available on devices such as the Watch GT 6 Pro smartwatch, currently priced at €314.90 on Amazon DE.
More Details Emerging
A leaker known as Fixed-Focus Digital on Weibo has suggested that Huawei is developing another wearable for blood glucose monitoring. The source claims that the technology in this upcoming model will be “more accurate” than that of the previous version, although no evidence has been shared to support this assertion. The design details of this new wearable are also still unknown. Huawei Central speculates that it may be an updated version of the Huawei Watch D, but does not clarify the origin of this claim.
Expected Release Timeline
Per Fixed-Focus Digital, Huawei plans to unveil this new blood sugar monitoring device in the second quarter of 2026, which means it could be launched sometime between early April and late June. It remains uncertain whether this product will be available only in China or if it will also reach other markets, including Europe.
Source:
Link


